期 |
标题 |
文件 |
编号 4 (2015) |
"Autoimmune" atypical hemolytic-uremic syndrome in a child - genetic carrier of multiple polymorphisms of hemostasis genes (clinical observation) |
|
Semeshina O., Luchaninova V., Kozlovskaja N., Gorelik N., Mel'nikova E., Mankevich T., Stepanjuk V., Grivachevskaja A., Emirova H., Generalova G., Ibragimova E.
|
编号 2 (2012) |
DIFFICULT NEPHROLOGICAL PATIENT TODAY |
|
Mukhin N., Moukhin N.
|
编号 2 (2011) |
PATIENT TRAINING AS AN APPROACH TO ENHANSING OF TREATMENT COMPLIANCE IN RENAL ARTERIAL HYPERTENSION |
|
Borovkova N., Borovkov N., Khor'kina Y., Maslova T., Pakhomova T.
|
编号 2 (2010) |
100 year anniversary of Kakovsky-Addis test |
|
- -.
|
编号 4 (2009) |
100-letie "Klinicheskikh lektsiy" G.A. Zakhar'ina |
|
Lazebnik L.
|
编号 4 (2009) |
40-TH YEAR ANNIVERSARY OF ALLUNION SCIENTIFIC SOCIETY OF NEPHROLOGISTS - RUSSIAN SCIENTIFIC SOCIETY OF NEPHROLOGY |
|
Androsova S.
|
编号 2 (2009) |
90-LET S MOMENTA OPISANIYa SINDROMA GUDPASChERA |
|
- -.
|
编号 3 (2018) |
ANCA-associated rapidly progressive glomerulonephritis |
|
Frolova N.
|
编号 2 (2010) |
Calcinosis of abdominal aorta in chronic kidney disease patients, not receiving renal replacement therapy |
|
Volkov M., Smirnov A., Degtereva O., Kirillova E., Gordeeva L., Volkov M., Smirnov A., Degtereva O., Kirillova E., Gordeeva L.
|
编号 4 (2009) |
CLINICAL SIGNIFICANCE OF DETERMINATION OR URINARY CONCENTRATION OF ENDOTHELIAL DYSFUNCTION AND FIBROGENESIS MARKERS IN HYPERTENSIVE NEPHROPATHY |
|
Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V., Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V.
|
编号 2 (2010) |
Comparison of distribution of erythropoietin medications isoforms with two-dimensional gel-electrophoresis |
|
Shnaider A.
|
卷 14, 编号 1 (2022) |
COVID-19 and viral dermal diseases in patients after renal transplantation |
|
Dymkov I., Perlina A., Terentiev I., Prokopenko E., Kulikov P., Perlin D.
|
卷 13, 编号 4 (2021) |
COVID-19 and kidney damage |
|
Mikhailova L., Sheleg D., Bogachev R.
|
编号 4 (2011) |
Specific adipokines in children with steroid-resistant nephrotic syndrome |
|
Kulina E., Osmanov I., Vozdvizhenskaya E.
|
编号 2 (2010) |
Early markers of diabetic nephropathy |
|
Bondar' I., Klimontov V., Bondar I., Klimontov V.
|
编号 3 (2011) |
Efficacy of aggressive immunosuppressive therapy in patient with fulminant Shoenlein-Henoch purpura |
|
Gulyaev S., Meshkov A., Novikov P., Semenovykh A., Nikiforova N., Nosova N.
|
编号 3 (2018) |
ERA-EDTA-2018: recent developments in the treatment of MCN-CKD |
|
- -.
|
编号 3 (2009) |
Frequently asked questions about glomerular filtration rate |
|
Arutyunov G., Oganezova L., Aroutiunov G., Oganesova L.
|
编号 4 (2009) |
FROM SARALASIN TO SARTANS: HISTORY OF THE ANGIOTENSIN II RECEPTOR BLOCKADE |
|
Fomin V., Kurashov M., Fomin V., Kurashov M.
|
编号 4 (2009) |
GOODPASTURE SYNDROME: FEATURES OF PATHOGENESIS, APPROACHES TO THE DIAGNOSIS AND TREATMENT |
|
Mukhin N.
|
编号 2 (2011) |
HCV-associated cryoglobulinemic vasculitis with severe kidney involvement and B-cell lymphoma development. Monoclonal anti-CD-20 antibodies and antiviral therapy as options of prognosis improvement |
|
Mukhin N., Kozlovskaya L., Milovanova L., Tegay S., Gordovskaya N., Ignatova T., Kudlinskiy I.
|
编号 2 (2014) |
IgM-NEPHROPATHY |
|
Batiushin M., Pasechnik D., Chistiakov V.
|
卷 13, 编号 1 (2021) |
KIM-1 as the biomarker of acute kidney injury in patients with the acute coronary syndrome and oncological diseases |
|
Mikhailova Z., Pivovarov D., Rumyantseva S., Pivovarova A.
|
编号 1 (2010) |
LOOP DIURETICS AND ANTIHYPERTENSIVE TREATMENT: FORGOTTEN PAST OR REAL PERSPECTIVE? |
|
Moiseev S., Fomin V., Moiseev S., Fomin V.
|
编号 4 (2009) |
NA+-K+-2CL-TRANSPORTER OF HENLE LOOP AS A TARGET FOR THE PHARMACOLOGICAL INTERVENTION |
|
- -.
|
编号 2 (2018) |
NGAL - marker of subclinical acute kidney injury in patients with acute coronary syndrome |
|
Shalenkova M., Mikhailova Z., Klimkin P.
|
卷 13, 编号 4 (2021) |
NGAL as a marker of acute kidney injury in sepsis |
|
Sharipova V., Berdiev N., Lutfullaev O., Zhabborova M.
|
编号 4 (2009) |
PECULIARITIES OF AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH ARTERIAL HYPERTENSION STAGES I - II WITH URIC ACID METABOLISM ABNORMALITIES |
|
Donskov A.
|
编号 4 (2009) |
POTENTIALS OF ANGIOTENSIN II RECEPTOR BLOCKERS IN HALTING THE PROGRESSION OF RENAL TRANSPLANT NEPHROPATHY |
|
Maksimov M.
|
编号 3 (2009) |
Problems of nephrology in 100-year history of Russian Scientific Medical Society of Internists |
|
Kokorin V., Kokorina M., Kokorin V., Kokorina M.
|
编号 2 (2009) |
Renal expression of hypoxia-induced factor-1, anemia and nephrosclerosis severity in chronic glomerulonephritis |
|
Shvetsov M., Ivanov A., Popova O., Kuznetsova A., Rameeva A., Shvetsov M., Ivanov A., Popova O., Kuznetsova A., Rameeva A.
|
编号 2 (2010) |
Renal oedema pathogenesis |
|
Tareev E., Ratner N., Tareev E., Ratner N.
|
编号 1 (2010) |
TO WHAT LEVEL WE MUST DECREASE SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS NOT SUFFERING FROM TYPE 2 DIABETES MELLITUS? |
|
Fomin V., Razuvaeva M., Fomin V., Razuvaeva M.
|
编号 2 (2010) |
Use of rituximab in severe ANCA-associated vasculitis |
|
Mukhin N., Semenkova E., Krivosheev O., Novikov P., Moukhin N., Semenkova E., Krivosheev O., Novikov P.
|
编号 2 (2013) |
Errent classification of systemic vasculitides: recommendations of International consensus conference (Chapel Hill 2012) |
|
Moiseev S., Semenkova E., Novikov P.
|
编号 4 (2017) |
Algorithms for the treatment of secondary hyperparathyroidism in patients with CKD stage 5D |
|
Volgina G., Mikhailova N., Shutov E., Kotenko O.
|
卷 12, 编号 3 (2020) |
Aleksey Yur'yevich Nikolayev |
|
- -.
|
编号 1 (2009) |
Allopurinol: indications and tactics of prescription |
|
Lebedeva M.
|
编号 1 (2009) |
Albuminuria as a marker of kidney injury and cardiovascular risk |
|
Mukhin N., Arutyunov G., Fomin V., Mukhin N., Arutyunov G., Fomin V.
|
编号 3 (2009) |
Albuminuria, plasma endothelin-1 and carotid atherosclerosis in patients with arterial hypertension and hyperuricemia |
|
Lebedeva M., Stakhova T., Balkarov I., Minakova E., Zaytseva L., Severova M., Shovskaya T., Lebedeva M., Stakhova T., Balkarov I., Minakova E., Zaitseva L., Severova M., Shovskaya T.
|
编号 4 (2017) |
Analysis of the effect of markers of kidney injury related to the carbohydrate metabolism disorders on the risk of non-selective proteinuria |
|
Ustinova M., Batiushin M.
|
卷 17, 编号 1 (2025) |
Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury |
|
Abdurakhimov A.
|
编号 4 (2011) |
Growth retardation and body mass deficiency in children with chronic kidney disease stage II - V (Russian registry of children with chronic renal failure) |
|
Molchanova M., Petrosyan E., Kazymova S., Molchanova E.
|
卷 14, 编号 4 (2022) |
Analysis of satisfaction with drug therapy for anemia in patients with stage 5 chronic kidney disease on hemodialysis |
|
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Dorofeeva E.
|
卷 15, 编号 4 (2023) |
Analysis of functional results of surgical treatment of kidney cancer |
|
Popov S., Guseynov R., Yesayan A., Sivak K., Perepelitsa V., Sadovnikova A., Grushevsky R., Lelyavina T.
|
编号 3 (2013) |
Prevalence of metabolic syndrome in early perioperative period after renal tranplantation |
|
Zagorodnikova N., Rzhevskaya O., Lazareva K., Shmarina N., Pinchuk A.
|
编号 3-4 (2016) |
Angiomyolipoma of own recipient’s kidney after allotransplantation of cadaveric kidney |
|
Yankovoy A., Sinyutin A., Stepanov V.
|
编号 6 (2011) |
Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta |
|
Fomin V., Kozlovskaya L., Milovanov Y.
|
编号 3 (2013) |
Anticoagulation on haemodyalisis: perspectives of low molecular weight heparins in dyalisis optimization |
|
Vishnevskiy K., Zamchenkov A., Gerasimchuk R.
|
编号 3 (2013) |
Antioxidants in nephrology: bardoxolone and diabetic nephropathy |
|
- -.
|
卷 15, 编号 4 (2023) |
Arterial hypertension in kidney transplantation – modern therapy strategy |
|
Nosov V., Koroleva L., Solovyanova E.
|
编号 6 (2011) |
JACCOUD'S ARTHRITIS IN PATIENT WITH TERMINAL LUPUS NEPHRITIS |
|
Ermolenko V., Zakharova E., Malkoch A., Vinogradova O., Tareeva A.
|
编号 5 (2013) |
Asimmetry in inborn kidney hypoplasy and children viability in dependence of affection lateralization |
|
Botvin'ev O., Safonova M.
|
卷 14, 编号 4 (2022) |
Assotsiatsiya «Professional'naya assotsiatsiya nefrologov» |
|
- -.
|
卷 13, 编号 2 (2021) |
Association of nephrolitiasis with arterial hypertension: gender specificities of comorbidity pathogenesis |
|
Barinov E., Grigoryan K., Malinin Y.
|
编号 5-6 (2012) |
Association of gene of glucocorticoid receptor polymorphism in children with steroid-resistant nephrotic syndrom |
|
Resnikov A., Tikhomirov E., Gavrilova V., Yurasova Y., Petrosian E.
|
编号 1 (2016) |
Association of polymorphic markers of TNF, IL 6 and IL10 genes with the clinical and morphological features of chronic glomerulonephritis |
|
Kamyshova E., Shvetsov M., Burdennyi A., Chzhen A., Kutyrina I., Nosikov V.
|
编号 3 (2014) |
Vasoactive hormones gene polymorphism and myocardial remodeling in chronic glomerulonephritis |
|
Kamyshova E., Shvetsov M., Kutyrina I., Rudenko T., Nosikov V.
|
编号 5-6 (2012) |
Association of prehypertension with risk factors of chronic kidney disease, arterial hypertension and atherosclerosis |
|
Burmagina A., Nikolaev A.
|
卷 13, 编号 4 (2021) |
Association of proteolysis factors with progression of autosomal dominant polycystic kidney disease in children |
|
Bashirova Z., Osmanov I.
|
编号 1 (2009) |
Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly |
|
Mukhin N., Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L., Mukhin N., M Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L.
|
编号 3-4 (2016) |
Pregnancy-associated atypical hemolytic uremic syndrome: life-saving therapy with ekulizumab |
|
Prokopenko E., Likhvantsev V., Vatazin A., Lopatin A., Guryeva V., Ostrovsky E., Fomin A., Ulitkina O.
|
编号 2 (2015) |
Atypical hemolytic uremic syndrome in pregnancy and hellp-syndrome. Differential diagnosis |
|
Batjushin M.
|
编号 3 (2011) |
Autosomal-dominant polycystic kidney disease: perspectives of treatment |
|
- -.
|
编号 1 (2015) |
Protein-energy malnutrition in peritoneal dialysis patients: risk factors and diagnosis |
|
Vetchinnikova O., Pichugina I.
|
编号 6 (2010) |
BENCE JONES PROTEIN |
|
- -.
|
卷 12, 编号 4 (2020) |
Bendopnea as a predictor of CHF decompensation in patients with CKD and COVID-19 |
|
Dragunov D., Sokolova A., Latyshev T., Arutyunov G.
|
编号 1 (2016) |
Pregnancy in a patient with renal tubular acidosis (clinical observation): management strategy, delivery and correction of metabolic disorders |
|
Upryamova E., Nikol'skaya I., Prokopenko E., Novikova S., Samko A., Bocharova I., Budykina T.
|
编号 2 (2009) |
Beta-blockers and renal continuum |
|
Arutyunov G., Oganezova L., Arutyunov G., Oganezova L.
|
卷 16, 编号 2 (2024) |
Biological significance of differentially expressed genes in hypoxic-ischemic acute kidney injury |
|
Popov S., Guseinov R., Yesayan A., Skryabin O., Vasin A., Kovalevskaya A., Perepelitsa V., Beshtoev A., Lelyavina T.
|
编号 4 (2014) |
Renal damage in patients with arterial hypertension and hyperuricemia: personalised approach to prognosis |
|
Muhin N., Kozlovskaya L., Fomin V., Stahova T., Lebedeva M., Balkarov I.
|
编号 1 (2015) |
Biomarkers for risk stratification in patients with atrial fibrillation and chronic kidney disease |
|
Fomin V., Kijakbaev G.
|
编号 5 (2014) |
Biometric predictors of kidney remodeling in pregnant women |
|
Konyshko N., Morozova T.
|
编号 2 (2018) |
The beneficial effect of fish oil on the idiopathic hypercalciuria in children |
|
Mikheeva N., Zverev Y., Vykhodtseva G., Lobanov Y.
|
卷 11, 编号 3 (2019) |
Immediate results of endovascular correction of renal artery stenosis |
|
Popov D., Solodushkin S., Stolyar A., Shardina L., Shardin S.
|
编号 5 (2010) |
ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ENALAPRIL IN HYPERTENSIVE PATIENTS WITH RENAL TRANSPALANT NEPHROPATHY |
|
Maksimov M.
|
编号 1 (2012) |
Angiotensin II receptor blocker valsartan and endothelial function in patients with chronic heart failure |
|
Gyamdzhyan K., Maksimov M., Kukes V., Giamdjan K., Maksimov M., Kukes V.
|
编号 3 (2010) |
Angiotensin II receptor blockers in arterial hypertension: when to start? |
|
- -.
|
编号 1 (2010) |
BERGER DISEASE |
|
- -.
|
编号 3 (2010) |
Bright disease |
|
- -.
|
编号 4 (2010) |
Bolezn' i smert' Mastera (o bolezni Mikhaila Bulgakova) |
|
Dvoretskiy L.
|
卷 15, 编号 2 (2023) |
Castleman's disease associated with amyloidosis. Literature review and clinical observation |
|
Frolova N., Varyasin V., Volgina G., Sysoeva I., Mudarisov R., Usatyuk S., Dyakova E., Stolyarevich E.
|
编号 5 (2011) |
de Toni-Debre-Fanconi disease (syndrome) |
|
- -.
|
编号 5 (2010) |
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura |
|
Fomin V., Pulin A., Rameev V., Sedov V., Meshkov A., Roshchupkina S., Panasyuk V., Kozlovskaya L., Mukhin N.
|
编号 1 (2018) |
Fabry disease: the main target organs in adults. Literature review |
|
Firsov K., Kotov A.
|
卷 14, 编号 2 (2022) |
Rapid elimination of small stones from the middle third of the ureter: mechanisms of modulation of contraction and relaxation of smooth muscle tissue |
|
Barinov E., Malinin Y., Grigoryan K.
|
编号 1 (2009) |
Heart rate variability, plasma renin activity and aldosterone level in chronic glomerulonephritis with arterial hypertension and normal renal function |
|
Borovkova N., Borovkov N., Sidnev B., Obukhova E., Borovkova N., Borovkov N., Sidnev B., Obuhova E.
|
编号 2 (2011) |
Variants of the lupous nephritis course |
|
Tareeva I.
|
编号 5-6 (2012) |
Renal function parameters and endothelial disfunction in patients with arterial hypertension |
|
Rebrov A., Kuklina A.
|
编号 2 (2017) |
Relationship of hyperchemerinemia and parameters of nutritive status in patients with chronic renal insufficiency |
|
Poganeva V., Batyushin M., Efimenko L.
|
卷 12, 编号 1 (2020) |
The relationship between the concentration of fibroblast growth factor-23 and central hemodynamics in patients with chronic kidney disease |
|
Murkamilov I.
|
编号 6 (2013) |
Interrelations between natriuresis, central hemodynamics parameters and plasma angiotensin II concentration |
|
Arutiunov G., Dragunov D., Sokolova A.
|
编号 1 (2015) |
Relationship of renal excretory function impairment to serum erythropoietin level in chronic heart failure |
|
Makarova N., Zaharov J.
|
编号 1 (2011) |
ASSOCIATION OF LEPTINEMIA AND ADIPONECTINEMIA WITH CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE |
|
Severova M., Saginova E., Gallyamov M., Ermakov N., Rodina A., Severov M., Fomin V., Mukhin N.
|
卷 12, 编号 1 (2020) |
The relationship of bendopnea and change in renal filtration function in patients with chronic heart failure |
|
Dragunov D., Sokolova A., Gasanova A., Arutyunov G.
|
卷 13, 编号 1 (2021) |
Relationship between tumor necrosis factor alpha and interleukin-10 and left ventricular remodeling in renal failure |
|
Murkamilov I., Sabirov I., Fomin V., Murkamilova Z., Kudaibergenova I., Yusupov F.
|
编号 6 (2014) |
A look at 175 years ago (B.Braun) |
|
- -.
|
编号 4 (2010) |
VICh-ASSOTsIIROVANNAYa NEFROPATIYa: STRATEGIYa DIAGNOSTIKI I LEChENIYa |
|
Mukhin N., Fomin V.
|
卷 12, 编号 4 (2020) |
The contribution of A.M. Shumlyansky (1748-1795), one of the founders of nephrology and microscopic anatomy in Russia, into clinical medicine (on the 225th anniversary of the death of the professor) |
|
Morgoshiya T., Belyaeva D.
|
编号 4 (2014) |
S.S. Zimnitsky contribution in development of nephrology in Russian Federation |
|
Maksudova A., Bombina L., Abdulganieva D., Nazarov M.
|
1 - 100 的 915 信息 |
1 2 3 4 5 6 7 8 9 10 > >> |